The impact of disagreement between prognostic risk scores on oncologic outcomes of metastatic renal cell carcinoma (mRCC) patients in the tyrosine-kinase inhibitor (TKI) era

The impact of disagreement between prognostic risk scores on oncologic outcomes of metastatic renal cell carcinoma (mRCC) patients in the tyrosine-kinase inhibitor (TKI) era

Bibliographic Details
Main Authors: F. Janisch, P. Marks, C.P. Meyer, H. Yu, C. Fühner, R. Dahlem, M. Abufaraj, S.F. Shariat, M. Fisch, M. Rink
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320333140

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320333140

Similar Items